Zogenix announces new efficacy and safety data for ZX008 in treatment of seizures
Zogenix announced new data demonstrating effectiveness and cardiovascular-related safety for patients treated with ZX008 (low-dose fenfluramine) as an adjunctive therapy for seizures associated with Lennox Gastaut Syndrome, and atients with Dravet syndrome. December 05, 2016